The involvement of central nervous system across the phenotypic spectrum of Pompe disease: a systematic review

•CNS involvement in Pompe disease is heterogeneous in clinical presentation and radiological features.•Arterial vessels, white and grey matter can be affected.•CNS affection is present both in IOPD and LOPD subjects.•No uniform methodology has been applied to study CNS.•Standardized protocols are ne...

Full description

Saved in:
Bibliographic Details
Published inNeuromuscular disorders : NMD Vol. 51; p. 105362
Main Authors Torri, Francesca, Buchignani, Bianca, Unluturk, Zeynep, Vadi, Gabriele, Loprieno, Sara, Battini, Roberta, Mancuso, Michelangelo, Siciliano, Gabriele
Format Journal Article
LanguageEnglish
Published England Elsevier B.V 01.06.2025
Subjects
Online AccessGet full text

Cover

Loading…
Abstract •CNS involvement in Pompe disease is heterogeneous in clinical presentation and radiological features.•Arterial vessels, white and grey matter can be affected.•CNS affection is present both in IOPD and LOPD subjects.•No uniform methodology has been applied to study CNS.•Standardized protocols are needed to characterize CNS involvement and adopt proper care strategies. Pompe disease is an inherited lysosomal disorder which results in glycogen buildup in various organs and tissues. The phenotypic spectrum of this disorder encompasses infantile and late-onset forms, with variable multisystem involvement. Affection of the central nervous system is known to variably present in infantile forms, while the incidence of disease-related alterations in older patients is more debated. PubMed, Web of Science and Scopus databases were searched for papers regarding brain and spinal cord abnormalities at imaging and pathology, neuropsychological assessment and clinical reports in Pompe disease, without chronological restrictions. The database search identified 609 records, then 282 full-text articles were retrieved for detailed examination. Of these records, 81 were selected, which presented heterogeneity in methodology and overall analyzed small cohorts. Our search highlights the current fragmented evidence presented in the field. It would be advisable to perform a routine CNS assessment at least by imaging and neuropsychological evaluation at the time of diagnosis and as part of a regular follow-up, for IOPD but also for LOPD patients, to better characterize the prevalence and clinical significance of CNS abnormalities and provide a tailored follow-up.
AbstractList •CNS involvement in Pompe disease is heterogeneous in clinical presentation and radiological features.•Arterial vessels, white and grey matter can be affected.•CNS affection is present both in IOPD and LOPD subjects.•No uniform methodology has been applied to study CNS.•Standardized protocols are needed to characterize CNS involvement and adopt proper care strategies. Pompe disease is an inherited lysosomal disorder which results in glycogen buildup in various organs and tissues. The phenotypic spectrum of this disorder encompasses infantile and late-onset forms, with variable multisystem involvement. Affection of the central nervous system is known to variably present in infantile forms, while the incidence of disease-related alterations in older patients is more debated. PubMed, Web of Science and Scopus databases were searched for papers regarding brain and spinal cord abnormalities at imaging and pathology, neuropsychological assessment and clinical reports in Pompe disease, without chronological restrictions. The database search identified 609 records, then 282 full-text articles were retrieved for detailed examination. Of these records, 81 were selected, which presented heterogeneity in methodology and overall analyzed small cohorts. Our search highlights the current fragmented evidence presented in the field. It would be advisable to perform a routine CNS assessment at least by imaging and neuropsychological evaluation at the time of diagnosis and as part of a regular follow-up, for IOPD but also for LOPD patients, to better characterize the prevalence and clinical significance of CNS abnormalities and provide a tailored follow-up.
Pompe disease is an inherited lysosomal disorder which results in glycogen buildup in various organs and tissues. The phenotypic spectrum of this disorder encompasses infantile and late-onset forms, with variable multisystem involvement. Affection of the central nervous system is known to variably present in infantile forms, while the incidence of disease-related alterations in older patients is more debated. PubMed, Web of Science and Scopus databases were searched for papers regarding brain and spinal cord abnormalities at imaging and pathology, neuropsychological assessment and clinical reports in Pompe disease, without chronological restrictions. The database search identified 609 records, then 282 full-text articles were retrieved for detailed examination. Of these records, 81 were selected, which presented heterogeneity in methodology and overall analyzed small cohorts. Our search highlights the current fragmented evidence presented in the field. It would be advisable to perform a routine CNS assessment at least by imaging and neuropsychological evaluation at the time of diagnosis and as part of a regular follow-up, for IOPD but also for LOPD patients, to better characterize the prevalence and clinical significance of CNS abnormalities and provide a tailored follow-up.Pompe disease is an inherited lysosomal disorder which results in glycogen buildup in various organs and tissues. The phenotypic spectrum of this disorder encompasses infantile and late-onset forms, with variable multisystem involvement. Affection of the central nervous system is known to variably present in infantile forms, while the incidence of disease-related alterations in older patients is more debated. PubMed, Web of Science and Scopus databases were searched for papers regarding brain and spinal cord abnormalities at imaging and pathology, neuropsychological assessment and clinical reports in Pompe disease, without chronological restrictions. The database search identified 609 records, then 282 full-text articles were retrieved for detailed examination. Of these records, 81 were selected, which presented heterogeneity in methodology and overall analyzed small cohorts. Our search highlights the current fragmented evidence presented in the field. It would be advisable to perform a routine CNS assessment at least by imaging and neuropsychological evaluation at the time of diagnosis and as part of a regular follow-up, for IOPD but also for LOPD patients, to better characterize the prevalence and clinical significance of CNS abnormalities and provide a tailored follow-up.
Pompe disease is an inherited lysosomal disorder which results in glycogen buildup in various organs and tissues. The phenotypic spectrum of this disorder encompasses infantile and late-onset forms, with variable multisystem involvement. Affection of the central nervous system is known to variably present in infantile forms, while the incidence of disease-related alterations in older patients is more debated. PubMed, Web of Science and Scopus databases were searched for papers regarding brain and spinal cord abnormalities at imaging and pathology, neuropsychological assessment and clinical reports in Pompe disease, without chronological restrictions. The database search identified 609 records, then 282 full-text articles were retrieved for detailed examination. Of these records, 81 were selected, which presented heterogeneity in methodology and overall analyzed small cohorts. Our search highlights the current fragmented evidence presented in the field. It would be advisable to perform a routine CNS assessment at least by imaging and neuropsychological evaluation at the time of diagnosis and as part of a regular follow-up, for IOPD but also for LOPD patients, to better characterize the prevalence and clinical significance of CNS abnormalities and provide a tailored follow-up.
ArticleNumber 105362
Author Torri, Francesca
Battini, Roberta
Unluturk, Zeynep
Loprieno, Sara
Siciliano, Gabriele
Vadi, Gabriele
Buchignani, Bianca
Mancuso, Michelangelo
Author_xml – sequence: 1
  givenname: Francesca
  orcidid: 0000-0002-1731-3500
  surname: Torri
  fullname: Torri, Francesca
  email: francesca.torri@phd.unipi.it
  organization: Department of Translational Research and of New Surgical and Medical Technologies, University of Pisa, Pisa, Italy
– sequence: 2
  givenname: Bianca
  surname: Buchignani
  fullname: Buchignani, Bianca
  organization: Department of Translational Research and of New Surgical and Medical Technologies, University of Pisa, Pisa, Italy
– sequence: 3
  givenname: Zeynep
  surname: Unluturk
  fullname: Unluturk, Zeynep
  organization: Neurology Clinic, University of Health Sciences Kocaeli Derince Training Hospital, Derince, Kocaeli, Turkey
– sequence: 4
  givenname: Gabriele
  surname: Vadi
  fullname: Vadi, Gabriele
  organization: Department of Clinical and Experimental Medicine, University of Pisa, Pisa, Italy
– sequence: 5
  givenname: Sara
  surname: Loprieno
  fullname: Loprieno, Sara
  organization: Department of Clinical and Experimental Medicine, University of Pisa, Pisa, Italy
– sequence: 6
  givenname: Roberta
  surname: Battini
  fullname: Battini, Roberta
  organization: IRCCS Fondazione Stella Maris, Pisa, Italy
– sequence: 7
  givenname: Michelangelo
  surname: Mancuso
  fullname: Mancuso, Michelangelo
  organization: Department of Clinical and Experimental Medicine, University of Pisa, Pisa, Italy
– sequence: 8
  givenname: Gabriele
  surname: Siciliano
  fullname: Siciliano, Gabriele
  organization: Department of Clinical and Experimental Medicine, University of Pisa, Pisa, Italy
BackLink https://www.ncbi.nlm.nih.gov/pubmed/40413934$$D View this record in MEDLINE/PubMed
BookMark eNqFkT1v2zAURYnCReO4_QFdAo5Z5PJDJK1kCow2CWCgHdKZoKgnhI5EqqSswP8-dOxk6NBODwTOIXDvPUczHzwg9JWSJSVUftsufd8sGWEivwWX7AOa05XiBeOynKE5qSQpVpWUZ-g8pS0hVCipPqGzkpSUV7ycI__wCNj5KXQT9OBHHFps842mwx7iFHYJp30aocfGxpASHrMwPIIP435wFqcB7Bh3_UH8FfoBcOMSmARX2JxMM2YuwuTg-TP62JouwZfTXaDfP74_rO-Kzc_b-_XNprBcqLGoQQClykAjSyoJqyyvSymEqqRSigFrV4yApEJArVpuaiaEqIG0q7ZRpWV8gS6P_w4x_NlBGnXvkoWuMx5yJM0ZUbKqylzDAl2c0F3dQ6OH6HoT9_qtowzQI_CaP0L7jlCiDzvorc476MMO-rhDdq6PDuSQOXjUyTrwFhoXc1-6Ce6fdvWXbTvnnTXdE-z_474A0d6jiQ
Cites_doi 10.1016/j.gim.2022.10.005
10.1212/WNL.0000000000207482
10.1007/s10545-007-0519-9
10.1038/s42003-021-02059-4
10.1016/j.jpeds.2014.10.068
10.1016/j.ymgme.2012.07.024
10.1016/j.ymgme.2023.108119
10.1186/s13023-018-0771-0
10.1016/j.jstrokecerebrovasdis.2018.06.043
10.3233/JND-230054
10.1007/s40291-024-00733-x
10.1002/mus.21076
10.1007/s13760-016-0738-7
10.1016/j.ebiom.2024.105323
10.1007/s10545-010-9144-0
10.3390/ijns10010003
10.3390/biom10091339
10.3389/fped.2024.1310317
10.1161/STROKEAHA.118.021964
10.1007/s10545-013-9601-7
10.3233/JND-230164
10.1016/j.ejpn.2018.08.001
10.1016/j.ymgme.2023.108121
10.1042/bj0860011
10.3109/14992027.2013.840932
10.1136/bjo.61.7.476
10.1016/j.nbd.2003.12.018
ContentType Journal Article
Copyright 2025 Elsevier B.V.
Copyright © 2025 Elsevier B.V. All rights reserved.
Copyright_xml – notice: 2025 Elsevier B.V.
– notice: Copyright © 2025 Elsevier B.V. All rights reserved.
DBID AAYXX
CITATION
CGR
CUY
CVF
ECM
EIF
NPM
7X8
DOI 10.1016/j.nmd.2025.105362
DatabaseName CrossRef
Medline
MEDLINE
MEDLINE (Ovid)
MEDLINE
MEDLINE
PubMed
MEDLINE - Academic
DatabaseTitle CrossRef
MEDLINE
Medline Complete
MEDLINE with Full Text
PubMed
MEDLINE (Ovid)
MEDLINE - Academic
DatabaseTitleList
MEDLINE - Academic
MEDLINE

Database_xml – sequence: 1
  dbid: NPM
  name: PubMed
  url: https://proxy.k.utb.cz/login?url=http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?db=PubMed
  sourceTypes: Index Database
– sequence: 2
  dbid: EIF
  name: MEDLINE
  url: https://proxy.k.utb.cz/login?url=https://www.webofscience.com/wos/medline/basic-search
  sourceTypes: Index Database
DeliveryMethod fulltext_linktorsrc
Discipline Medicine
EISSN 1873-2364
ExternalDocumentID 40413934
10_1016_j_nmd_2025_105362
S0960896625000896
Genre Systematic Review
Journal Article
GroupedDBID ---
--K
--M
.1-
.FO
.GJ
.~1
0R~
123
1B1
1P~
1RT
1~.
1~5
29N
4.4
457
4G.
53G
5VS
7-5
71M
8P~
9JM
AABNK
AAEDT
AAEDW
AAIKJ
AAKOC
AALRI
AAOAW
AAQFI
AAQXK
AATTM
AAXKI
AAXLA
AAXUO
AAYWO
ABBQC
ABCQJ
ABFNM
ABFRF
ABJNI
ABLJU
ABMAC
ABMZM
ABTEW
ABWVN
ABXDB
ACDAQ
ACGFO
ACGFS
ACIEU
ACIUM
ACRLP
ACRPL
ACVFH
ADBBV
ADCNI
ADEZE
ADMUD
ADNMO
ADVLN
AEBSH
AEFWE
AEIPS
AEKER
AENEX
AEUPX
AEVXI
AFJKZ
AFPUW
AFRHN
AFTJW
AFXIZ
AGCQF
AGHFR
AGQPQ
AGUBO
AGWIK
AGYEJ
AHHHB
AIEXJ
AIGII
AIIUN
AIKHN
AITUG
AJRQY
AJUYK
AKBMS
AKRLJ
AKRWK
AKYEP
ALMA_UNASSIGNED_HOLDINGS
AMRAJ
ANKPU
ANZVX
APXCP
ASPBG
AVWKF
AXJTR
AZFZN
BKOJK
BLXMC
BNPGV
CS3
DU5
EBS
EFJIC
EFKBS
EJD
EO8
EO9
EP2
EP3
F5P
FDB
FEDTE
FGOYB
FIRID
FNPLU
FYGXN
G-2
G-Q
GBLVA
HDW
HMK
HMO
HMQ
HVGLF
HZ~
IHE
J1W
KOM
LX8
M29
M2V
M41
MO0
MOBAO
N9A
O-L
O9-
OAUVE
OP~
OZT
P-8
P-9
P2P
PC.
Q38
R2-
ROL
RPZ
SAE
SCC
SDF
SDG
SDP
SEL
SES
SEW
SNS
SPCBC
SSH
SSN
SSZ
T5K
UHS
UNMZH
WUQ
Z5R
~G-
AFCTW
AGRNS
RIG
AAYXX
CITATION
CGR
CUY
CVF
ECM
EIF
NPM
7X8
ID FETCH-LOGICAL-c357t-be5e117aed6416029c3b46557967772e2f820e6155eb7f3ab2555be0f8fd74c23
IEDL.DBID .~1
ISSN 0960-8966
1873-2364
IngestDate Wed Jul 02 02:55:34 EDT 2025
Wed Jul 30 01:49:55 EDT 2025
Thu Jul 03 08:22:52 EDT 2025
Sat Jul 19 17:11:49 EDT 2025
Tue Aug 26 16:36:17 EDT 2025
IsPeerReviewed true
IsScholarly true
Keywords Pompe disease
White matter lesions, Aneurysm
brain MRI
Central nervous system
Cognitive impairment
Language English
License Copyright © 2025 Elsevier B.V. All rights reserved.
LinkModel DirectLink
MergedId FETCHMERGED-LOGICAL-c357t-be5e117aed6416029c3b46557967772e2f820e6155eb7f3ab2555be0f8fd74c23
Notes ObjectType-Article-1
SourceType-Scholarly Journals-1
ObjectType-Feature-2
ObjectType-Review-3
content type line 23
ORCID 0000-0002-1731-3500
PMID 40413934
PQID 3207699441
PQPubID 23479
ParticipantIDs proquest_miscellaneous_3207699441
pubmed_primary_40413934
crossref_primary_10_1016_j_nmd_2025_105362
elsevier_sciencedirect_doi_10_1016_j_nmd_2025_105362
elsevier_clinicalkey_doi_10_1016_j_nmd_2025_105362
PublicationCentury 2000
PublicationDate 2025-06-01
PublicationDateYYYYMMDD 2025-06-01
PublicationDate_xml – month: 06
  year: 2025
  text: 2025-06-01
  day: 01
PublicationDecade 2020
PublicationPlace England
PublicationPlace_xml – name: England
PublicationTitle Neuromuscular disorders : NMD
PublicationTitleAlternate Neuromuscul Disord
PublicationYear 2025
Publisher Elsevier B.V
Publisher_xml – name: Elsevier B.V
References Parini, De Lorenzo, Dardis, Burlina, Cassio, Cavarzere (bib0013) 2018; 13
Pfrimmer, Smitka, Muschol, Husain, Huemer, Hennermann (bib0014) 2024; 11
Sandhu, Rizvi, Kim, Reshi (bib0012) 2014; 7
Borroni, Cotelli, Premi, Gazzina, Cosseddu, Formenti (bib0009) 2013; 36
Kenney-Jung, Korlimarla, Spiridigliozzi, Wiggins, Malinzak, Nichting (bib0028) 2024; 141
Kamphoven, de Ruiter, Winkel, Van den Hout, Bijman, De Zeeuw (bib0016) 2004; 16
Page, McKenzie, Bossuyt, Boutron, Hoffmann, Mulrow (bib0005) 2021; 372
Colella (bib0004) 2024
van Capelle, Goedegebure, Homans, Hoeve, Reuser, van der Ploeg (bib0017) 2010; 33
Hsu, Chien, Shinn-Forng Peng, Hwu, Lee, Lee (bib0020) 2023; 25
Glascock, Darras, Crawford, Sumner, Kolb, DiDonato (bib0031) 2023; 10
Dornelles, Junges, Krug, Gonçalves, de Oliveira Junior, Schwartz (bib0024) 2024; 12
Toscano, Pollissard, Msihid, van der Beek, Kishnani, Dimachkie (bib0026) 2024; 141
Hossain, Miyajima, Akiyama, Eto (bib0010) 2018; 27
Koeberl, Kishnani, Chen (bib0023) 2007; 30
Shah, Liong, Levy, Waters, Fahn, Marder (bib0007) 2018; 49
Brettschneider, Sperfeld, Ludolph, Kassubek (bib0011) 2008; 38
Mackenbach, Willemse, van den Dorpel, van der Beek, Díaz-Manera, Rizopoulos (bib0022) 2023; 101
Chien, Lee, Chen, Tsai, Tsai, Shieh (bib0015) 2015; 166
Wang, Zhou, Khodabukus, Tran, Han, Carlson (bib0029) 2021; 4
G (bib0001) 1 January 1963; 86
Ricci, Brusa, Rossi, Rolle, Placentino, Berardinelli (bib0027) 2018; 22
Benatar, Macklin, Malaspina, Rogers, Hornstein, Lombardi (bib0030) 2024; 108
Meena, Raben (bib0002) 2020; 10
Kenney-Jung, Korlimarla, Spiridigliozzi, Wiggins, Malinzak, Nichting (bib0003) 2024; 141
.
Gragnaniello, Cazzorla, Gueraldi, Puma, Loro, Porcù (bib0025) 2023; 10
Bekircan-Kurt, Güneş, Yildiz, Saka, Tan, Erdem-Özdamar (bib0008) 2017; 117
Libert, Martin, Ceuterick, Danis (bib0021) 1977; 61
Hanisch, Rahne, Plontke (bib0019) 2013; 52
Musumeci, Catalano, Barca, Ravaglia, Fiumara, Gangemi (bib0018) 2012; 107
Sandhu (10.1016/j.nmd.2025.105362_bib0012) 2014; 7
G (10.1016/j.nmd.2025.105362_bib0001) 1963; 86
Kenney-Jung (10.1016/j.nmd.2025.105362_bib0028) 2024; 141
Pfrimmer (10.1016/j.nmd.2025.105362_bib0014) 2024; 11
Brettschneider (10.1016/j.nmd.2025.105362_bib0011) 2008; 38
Page (10.1016/j.nmd.2025.105362_bib0005) 2021; 372
Mackenbach (10.1016/j.nmd.2025.105362_bib0022) 2023; 101
Wang (10.1016/j.nmd.2025.105362_bib0029) 2021; 4
Meena (10.1016/j.nmd.2025.105362_bib0002) 2020; 10
Glascock (10.1016/j.nmd.2025.105362_bib0031) 2023; 10
Kenney-Jung (10.1016/j.nmd.2025.105362_bib0003) 2024; 141
Gragnaniello (10.1016/j.nmd.2025.105362_bib0025) 2023; 10
Parini (10.1016/j.nmd.2025.105362_bib0013) 2018; 13
Benatar (10.1016/j.nmd.2025.105362_bib0030) 2024; 108
Libert (10.1016/j.nmd.2025.105362_bib0021) 1977; 61
Hanisch (10.1016/j.nmd.2025.105362_bib0019) 2013; 52
Chien (10.1016/j.nmd.2025.105362_bib0015) 2015; 166
Shah (10.1016/j.nmd.2025.105362_bib0007) 2018; 49
Hossain (10.1016/j.nmd.2025.105362_bib0010) 2018; 27
Musumeci (10.1016/j.nmd.2025.105362_bib0018) 2012; 107
10.1016/j.nmd.2025.105362_bib0006
Kamphoven (10.1016/j.nmd.2025.105362_bib0016) 2004; 16
Koeberl (10.1016/j.nmd.2025.105362_bib0023) 2007; 30
Dornelles (10.1016/j.nmd.2025.105362_bib0024) 2024; 12
Ricci (10.1016/j.nmd.2025.105362_bib0027) 2018; 22
Bekircan-Kurt (10.1016/j.nmd.2025.105362_bib0008) 2017; 117
Toscano (10.1016/j.nmd.2025.105362_bib0026) 2024; 141
Borroni (10.1016/j.nmd.2025.105362_bib0009) 2013; 36
Hsu (10.1016/j.nmd.2025.105362_bib0020) 2023; 25
Colella (10.1016/j.nmd.2025.105362_bib0004) 2024
van Capelle (10.1016/j.nmd.2025.105362_bib0017) 2010; 33
References_xml – volume: 10
  start-page: 1339
  year: 2020
  ident: bib0002
  article-title: Pompe Disease: New Developments in an Old Lysosomal Storage Disorder
  publication-title: Biomolecules
– volume: 22
  start-page: 1103
  year: 2018
  end-page: 1109
  ident: bib0027
  article-title: Functional assessment tools in children with Pompe disease: A pilot comparative study to identify suitable outcome measures for the standard of care
  publication-title: European journal of paediatric neurology: EJPN: official journal of the European Paediatric Neurology Society
– volume: 141
  year: 2024
  ident: bib0003
  article-title: Severe CNS involvement in a subset of long-term treated children with infantile-onset Pompe disease
  publication-title: Molecular genetics and metabolism
– volume: 141
  year: 2024
  ident: bib0028
  article-title: Severe CNS involvement in a subset of long-term treated children with infantile-onset Pompe disease
  publication-title: Molecular genetics and metabolism
– volume: 16
  start-page: 14
  year: 2004
  end-page: 20
  ident: bib0016
  article-title: Hearing loss in infantile Pompe's disease and determination of underlying pathology in the knockout mouse
  publication-title: Neurobiology of disease
– volume: 117
  start-page: 269
  year: 2017
  end-page: 275
  ident: bib0008
  article-title: New mutations and genotype-phenotype correlation in late-onset Pompe patients
  publication-title: Acta Neurol Belg
– volume: 30
  start-page: 159
  year: 2007
  end-page: 164
  ident: bib0023
  article-title: Glycogen storage disease types I and II: treatment updates
  publication-title: J Inherit Metab Dis
– volume: 13
  start-page: 32
  year: 2018
  ident: bib0013
  article-title: Long term clinical history of an Italian cohort of infantile onset Pompe disease treated with enzyme replacement therapy
  publication-title: Orphanet journal of rare diseases
– volume: 61
  start-page: 476
  year: 1977
  end-page: 482
  ident: bib0021
  article-title: Ocular ultrastructural study in a fetus with type II glycogenosis
  publication-title: Br J Ophthalmol
– volume: 86
  start-page: 11
  year: 1 January 1963
  end-page: 16
  ident: bib0001
  article-title: Hers; α-Glucosidase deficiency in generalized glycogen-storage disease (Pompe's disease)
  publication-title: Biochem J
– volume: 107
  start-page: 480
  year: 2012
  end-page: 484
  ident: bib0018
  article-title: Auditory system involvement in late onset Pompe disease: a study of 20 Italian patients
  publication-title: Molecular genetics and metabolism
– volume: 7
  start-page: 82
  year: 2014
  end-page: 85
  ident: bib0012
  article-title: Diffuse cerebral microhemorrhages in a patient with adult-onset Pompe's disease: a case report
  publication-title: J Vasc Interv Neurol
– volume: 49
  start-page: 1977
  year: 2018
  end-page: 1980
  ident: bib0007
  article-title: Association of Low Lysosomal Enzymes Activity With Brain Arterial Dilatation
  publication-title: Stroke
– volume: 10
  start-page: 3
  year: 2023
  ident: bib0025
  article-title: Light and Shadows in Newborn Screening for Lysosomal Storage Disorders: Eight Years of Experience in Northeast Italy
  publication-title: International journal of neonatal screening
– volume: 372
  start-page: n71
  year: 2021
  ident: bib0005
  article-title: The PRISMA 2020 statement: an updated guideline for reporting systematic reviews
  publication-title: BMJ (Clinical research ed.)
– volume: 141
  year: 2024
  ident: bib0026
  article-title: Effect of avalglucosidase alfa on disease-specific and general patient-reported outcomes in treatment-naïve adults with late-onset Pompe disease compared with alglucosidase alfa: Meaningful change analyses from the Phase 3 COMET trial
  publication-title: Molecular genetics and metabolism
– volume: 101
  start-page: e594
  year: 2023
  end-page: e601
  ident: bib0022
  article-title: Neurofilament Light and Its Association With CNS Involvement in Patients With Classic Infantile Pompe Disease
  publication-title: Neurology,
– volume: 27
  start-page: 3046
  year: 2018
  end-page: 3052
  ident: bib0010
  article-title: A Case of Adult-onset Pompe Disease with Cerebral Stroke and Left Ventricular Hypertrophy
  publication-title: J Stroke Cerebrovasc Dis
– volume: 33
  start-page: 597
  year: 2010
  end-page: 602
  ident: bib0017
  article-title: Hearing loss in Pompe disease revisited: results from a study of 24 children
  publication-title: J Inherit Metab Dis
– volume: 11
  start-page: 167
  year: 2024
  end-page: 177
  ident: bib0014
  article-title: Long-Term Outcome of Infantile Onset Pompe Disease Patients Treated with Enzyme Replacement Therapy - Data from a German-Austrian Cohort
  publication-title: Journal of neuromuscular diseases
– reference: .
– volume: 52
  start-page: 816
  year: 2013
  end-page: 823
  ident: bib0019
  article-title: Prevalence of hearing loss in patients with late-onset Pompe disease: Audiological and otological consequences
  publication-title: Int J Audiol
– volume: 12
  year: 2024
  ident: bib0024
  article-title: Efficacy and safety of enzyme replacement therapy with alglucosidase alfa for the treatment of patients with infantile-onset Pompe disease: a systematic review and metanalysis
  publication-title: Front Pediatr
– volume: 25
  start-page: 27
  year: 2023
  end-page: 36
  ident: bib0020
  article-title: Evaluating brain white matter hyperintensity, IQ scores, and plasma neurofilament light chain concentration in early-treated patients with infantile-onset Pompe disease
  publication-title: Genetics in medicine: official journal of the American College of Medical Genetics
– volume: 36
  start-page: 989
  year: 2013
  end-page: 995
  ident: bib0009
  article-title: The brain in late-onset glycogenosis II: a structural and functional MRI study
  publication-title: Journal of inherited metabolic disease
– volume: 38
  start-page: 1211
  year: 2008
  end-page: 1212
  ident: bib0011
  article-title: Intracerebral hemorrhage in a patient with glycogenosis type II (Pompe disease): is there a pathophysiological relationship?
  publication-title: Muscle Nerve
– volume: 166
  start-page: 985
  year: 2015
  end-page: 991
  ident: bib0015
  article-title: Long-term prognosis of patients with infantile-onset Pompe disease diagnosed by newborn screening and treated since birth
  publication-title: The Journal of pediatrics
– volume: 4
  start-page: 524
  year: 2021
  ident: bib0029
  article-title: Three-dimensional tissue-engineered human skeletal muscle model of Pompe disease
  publication-title: Communications biology
– volume: 10
  start-page: 937
  year: 2023
  end-page: 954
  ident: bib0031
  article-title: Identifying Biomarkers of Spinal Muscular Atrophy for Further Development
  publication-title: Journal of neuromuscular diseases
– year: 2024
  ident: bib0004
  article-title: Advances in Pompe Disease Treatment: From Enzyme Replacement to Gene Therapy
  publication-title: Mol Diagn Ther
– volume: 108
  year: 2024
  ident: bib0030
  article-title: Prognostic clinical and biological markers for amyotrophic lateral sclerosis disease progression: validation and implications for clinical trial design and analysis
  publication-title: EBioMedicine
– volume: 25
  start-page: 27
  issue: 1
  year: 2023
  ident: 10.1016/j.nmd.2025.105362_bib0020
  article-title: Evaluating brain white matter hyperintensity, IQ scores, and plasma neurofilament light chain concentration in early-treated patients with infantile-onset Pompe disease
  publication-title: Genetics in medicine: official journal of the American College of Medical Genetics
  doi: 10.1016/j.gim.2022.10.005
– volume: 101
  start-page: e594
  issue: 6
  year: 2023
  ident: 10.1016/j.nmd.2025.105362_bib0022
  article-title: Neurofilament Light and Its Association With CNS Involvement in Patients With Classic Infantile Pompe Disease
  publication-title: Neurology,
  doi: 10.1212/WNL.0000000000207482
– volume: 30
  start-page: 159
  issue: 2
  year: 2007
  ident: 10.1016/j.nmd.2025.105362_bib0023
  article-title: Glycogen storage disease types I and II: treatment updates
  publication-title: J Inherit Metab Dis
  doi: 10.1007/s10545-007-0519-9
– volume: 4
  start-page: 524
  issue: 1
  year: 2021
  ident: 10.1016/j.nmd.2025.105362_bib0029
  article-title: Three-dimensional tissue-engineered human skeletal muscle model of Pompe disease
  publication-title: Communications biology
  doi: 10.1038/s42003-021-02059-4
– volume: 7
  start-page: 82
  issue: 5
  year: 2014
  ident: 10.1016/j.nmd.2025.105362_bib0012
  article-title: Diffuse cerebral microhemorrhages in a patient with adult-onset Pompe's disease: a case report
  publication-title: J Vasc Interv Neurol
– volume: 166
  start-page: 985
  issue: 4
  year: 2015
  ident: 10.1016/j.nmd.2025.105362_bib0015
  article-title: Long-term prognosis of patients with infantile-onset Pompe disease diagnosed by newborn screening and treated since birth
  publication-title: The Journal of pediatrics
  doi: 10.1016/j.jpeds.2014.10.068
– volume: 107
  start-page: 480
  issue: 3
  year: 2012
  ident: 10.1016/j.nmd.2025.105362_bib0018
  article-title: Auditory system involvement in late onset Pompe disease: a study of 20 Italian patients
  publication-title: Molecular genetics and metabolism
  doi: 10.1016/j.ymgme.2012.07.024
– volume: 141
  issue: 2
  year: 2024
  ident: 10.1016/j.nmd.2025.105362_bib0028
  article-title: Severe CNS involvement in a subset of long-term treated children with infantile-onset Pompe disease
  publication-title: Molecular genetics and metabolism
  doi: 10.1016/j.ymgme.2023.108119
– volume: 13
  start-page: 32
  issue: 1
  year: 2018
  ident: 10.1016/j.nmd.2025.105362_bib0013
  article-title: Long term clinical history of an Italian cohort of infantile onset Pompe disease treated with enzyme replacement therapy
  publication-title: Orphanet journal of rare diseases
  doi: 10.1186/s13023-018-0771-0
– volume: 27
  start-page: 3046
  issue: 11
  year: 2018
  ident: 10.1016/j.nmd.2025.105362_bib0010
  article-title: A Case of Adult-onset Pompe Disease with Cerebral Stroke and Left Ventricular Hypertrophy
  publication-title: J Stroke Cerebrovasc Dis
  doi: 10.1016/j.jstrokecerebrovasdis.2018.06.043
– volume: 10
  start-page: 937
  issue: 5
  year: 2023
  ident: 10.1016/j.nmd.2025.105362_bib0031
  article-title: Identifying Biomarkers of Spinal Muscular Atrophy for Further Development
  publication-title: Journal of neuromuscular diseases
  doi: 10.3233/JND-230054
– year: 2024
  ident: 10.1016/j.nmd.2025.105362_bib0004
  article-title: Advances in Pompe Disease Treatment: From Enzyme Replacement to Gene Therapy
  publication-title: Mol Diagn Ther
  doi: 10.1007/s40291-024-00733-x
– volume: 38
  start-page: 1211
  issue: 3
  year: 2008
  ident: 10.1016/j.nmd.2025.105362_bib0011
  article-title: Intracerebral hemorrhage in a patient with glycogenosis type II (Pompe disease): is there a pathophysiological relationship?
  publication-title: Muscle Nerve
  doi: 10.1002/mus.21076
– volume: 117
  start-page: 269
  issue: 1
  year: 2017
  ident: 10.1016/j.nmd.2025.105362_bib0008
  article-title: New mutations and genotype-phenotype correlation in late-onset Pompe patients
  publication-title: Acta Neurol Belg
  doi: 10.1007/s13760-016-0738-7
– volume: 108
  year: 2024
  ident: 10.1016/j.nmd.2025.105362_bib0030
  article-title: Prognostic clinical and biological markers for amyotrophic lateral sclerosis disease progression: validation and implications for clinical trial design and analysis
  publication-title: EBioMedicine
  doi: 10.1016/j.ebiom.2024.105323
– volume: 33
  start-page: 597
  issue: 5
  year: 2010
  ident: 10.1016/j.nmd.2025.105362_bib0017
  article-title: Hearing loss in Pompe disease revisited: results from a study of 24 children
  publication-title: J Inherit Metab Dis
  doi: 10.1007/s10545-010-9144-0
– volume: 10
  start-page: 3
  issue: 1
  year: 2023
  ident: 10.1016/j.nmd.2025.105362_bib0025
  article-title: Light and Shadows in Newborn Screening for Lysosomal Storage Disorders: Eight Years of Experience in Northeast Italy
  publication-title: International journal of neonatal screening
  doi: 10.3390/ijns10010003
– volume: 10
  start-page: 1339
  issue: 9
  year: 2020
  ident: 10.1016/j.nmd.2025.105362_bib0002
  article-title: Pompe Disease: New Developments in an Old Lysosomal Storage Disorder
  publication-title: Biomolecules
  doi: 10.3390/biom10091339
– volume: 12
  year: 2024
  ident: 10.1016/j.nmd.2025.105362_bib0024
  article-title: Efficacy and safety of enzyme replacement therapy with alglucosidase alfa for the treatment of patients with infantile-onset Pompe disease: a systematic review and metanalysis
  publication-title: Front Pediatr
  doi: 10.3389/fped.2024.1310317
– ident: 10.1016/j.nmd.2025.105362_bib0006
– volume: 49
  start-page: 1977
  issue: 8
  year: 2018
  ident: 10.1016/j.nmd.2025.105362_bib0007
  article-title: Association of Low Lysosomal Enzymes Activity With Brain Arterial Dilatation
  publication-title: Stroke
  doi: 10.1161/STROKEAHA.118.021964
– volume: 36
  start-page: 989
  issue: 6
  year: 2013
  ident: 10.1016/j.nmd.2025.105362_bib0009
  article-title: The brain in late-onset glycogenosis II: a structural and functional MRI study
  publication-title: Journal of inherited metabolic disease
  doi: 10.1007/s10545-013-9601-7
– volume: 11
  start-page: 167
  issue: 1
  year: 2024
  ident: 10.1016/j.nmd.2025.105362_bib0014
  article-title: Long-Term Outcome of Infantile Onset Pompe Disease Patients Treated with Enzyme Replacement Therapy - Data from a German-Austrian Cohort
  publication-title: Journal of neuromuscular diseases
  doi: 10.3233/JND-230164
– volume: 22
  start-page: 1103
  issue: 6
  year: 2018
  ident: 10.1016/j.nmd.2025.105362_bib0027
  article-title: Functional assessment tools in children with Pompe disease: A pilot comparative study to identify suitable outcome measures for the standard of care
  publication-title: European journal of paediatric neurology: EJPN: official journal of the European Paediatric Neurology Society
  doi: 10.1016/j.ejpn.2018.08.001
– volume: 141
  issue: 2
  year: 2024
  ident: 10.1016/j.nmd.2025.105362_bib0026
  article-title: Effect of avalglucosidase alfa on disease-specific and general patient-reported outcomes in treatment-naïve adults with late-onset Pompe disease compared with alglucosidase alfa: Meaningful change analyses from the Phase 3 COMET trial
  publication-title: Molecular genetics and metabolism
  doi: 10.1016/j.ymgme.2023.108121
– volume: 86
  start-page: 11
  issue: 1
  year: 1963
  ident: 10.1016/j.nmd.2025.105362_bib0001
  article-title: Hers; α-Glucosidase deficiency in generalized glycogen-storage disease (Pompe's disease)
  publication-title: Biochem J
  doi: 10.1042/bj0860011
– volume: 52
  start-page: 816
  issue: 12
  year: 2013
  ident: 10.1016/j.nmd.2025.105362_bib0019
  article-title: Prevalence of hearing loss in patients with late-onset Pompe disease: Audiological and otological consequences
  publication-title: Int J Audiol
  doi: 10.3109/14992027.2013.840932
– volume: 61
  start-page: 476
  issue: 7
  year: 1977
  ident: 10.1016/j.nmd.2025.105362_bib0021
  article-title: Ocular ultrastructural study in a fetus with type II glycogenosis
  publication-title: Br J Ophthalmol
  doi: 10.1136/bjo.61.7.476
– volume: 372
  start-page: n71
  year: 2021
  ident: 10.1016/j.nmd.2025.105362_bib0005
  article-title: The PRISMA 2020 statement: an updated guideline for reporting systematic reviews
  publication-title: BMJ (Clinical research ed.)
– volume: 16
  start-page: 14
  issue: 1
  year: 2004
  ident: 10.1016/j.nmd.2025.105362_bib0016
  article-title: Hearing loss in infantile Pompe's disease and determination of underlying pathology in the knockout mouse
  publication-title: Neurobiology of disease
  doi: 10.1016/j.nbd.2003.12.018
– volume: 141
  issue: 2
  year: 2024
  ident: 10.1016/j.nmd.2025.105362_bib0003
  article-title: Severe CNS involvement in a subset of long-term treated children with infantile-onset Pompe disease
  publication-title: Molecular genetics and metabolism
  doi: 10.1016/j.ymgme.2023.108119
SSID ssj0015767
Score 2.4307547
SecondaryResourceType review_article
Snippet •CNS involvement in Pompe disease is heterogeneous in clinical presentation and radiological features.•Arterial vessels, white and grey matter can be...
Pompe disease is an inherited lysosomal disorder which results in glycogen buildup in various organs and tissues. The phenotypic spectrum of this disorder...
SourceID proquest
pubmed
crossref
elsevier
SourceType Aggregation Database
Index Database
Publisher
StartPage 105362
SubjectTerms Brain - diagnostic imaging
Brain - pathology
brain MRI
Central nervous system
Central Nervous System - pathology
Cognitive impairment
Glycogen Storage Disease Type II - complications
Glycogen Storage Disease Type II - pathology
Glycogen Storage Disease Type II - physiopathology
Humans
Phenotype
Pompe disease
Spinal Cord - diagnostic imaging
Spinal Cord - pathology
White matter lesions, Aneurysm
Title The involvement of central nervous system across the phenotypic spectrum of Pompe disease: a systematic review
URI https://www.clinicalkey.com/#!/content/1-s2.0-S0960896625000896
https://dx.doi.org/10.1016/j.nmd.2025.105362
https://www.ncbi.nlm.nih.gov/pubmed/40413934
https://www.proquest.com/docview/3207699441
Volume 51
hasFullText 1
inHoldings 1
isFullTextHit
isPrint
link http://utb.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwnV1LS8NAEF6KgngR39ZHWcGTEJvsbh7rrRRLVVoELfS27G42UKFpkXjw4m93Jo-Khyp4S8IO2cxsvvk28wghV9JPrNGZ9iRLYIMCDsjTvuFeYAEyExMYbfF7x2gcDSfiYRpOW6Tf1MJgWmWN_RWml2hdX-nW2uwuZ7PuM5LvBNg6w57-cIAV7CLGVX7zuUrzCIBPlyXTMNjD0U1ks8zxyufYLJSF-LdbHrF1vmkd9yx90GCX7NTkkfaq-e2Rlsv3ydaoDo8fkByMTmc5IE7ZBbygi4zW2Zc0B1CAXT6tWjdTXU6BAv2jmOW1KD6WM0vLusu39zkKPiGjpnUA55Zq-t30mVYFL4dkMrh76Q-9-ocKnuVhXHjGhS4IYu3SCHiYz6TlBvunxTKKgWU7lgEfcBipdCbOuDaw3wiN87MkS2NhGT8iG_kidyeEJjJMhZGZTVIpRGh1wMGsmdQ6CtMosm1y3ahSLau-GapJKHtVoHeFeleV3tuENcpWTUEoQJgCVP9NSKyEfqyYv8QuG2sqeJMwPKJzB_pXnPlxJOFpgjY5rsy8mrrwwdlLLk7_d9Mzso1nVYrZOdkAS7oLIDOF6ZSrtUM2e_ePw_EXQybzYA
linkProvider Elsevier
linkToHtml http://utb.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwnV1JS8QwFH6MI6gXcXdcI3gS6rRJusSbDA7jMiLogLeQpClUmM4g48GLv92XLiMeVPBW2jyavpd8-dK3BOBU-InRKlOeoAluUHAB8pSvmRcYhMxEB1oZ979jeB8NRvzmOXxuQa_JhXFhlTX2V5heonV9p1trszvN8-6jI98JsnXqavrjxQIscpy-7hiD8495nEeAhLrMmcbWnmveuDbLIK9i7KqF0tAdd8si-tPi9BP5LBeh_hqs1uyRXFYdXIeWLTZgaVj7xzehQKuTvEDIKcuAz8gkI3X4JSkQFXCbT6razUSVXSDI_4gL85rM3qe5IWXi5evb2Ak-OEpNag_OBVHkq-ozqTJetmDUv3rqDbz6RAXPsDCeedqGNghiZdMIiZhPhWHaFVCLRRQjzbY0Q0JgnavS6jhjSuOGI9TWz5IsjbmhbBvaxaSwu0ASEaZci8wkqeA8NCpgaNdMKBWFaRSZDpw1qpTTqnCGbCLKXiTqXTq9y0rvHaCNsmWTEYoYJhHWfxPic6FvQ-YvsZPGmhKnkvOPqMKi_iWjfhwJ_JqgAzuVmedd5z6u9oLxvf-99BiWB0_DO3l3fX-7DyvuSRVvdgBttKo9RGYz00flyP0E0-T07g
openUrl ctx_ver=Z39.88-2004&ctx_enc=info%3Aofi%2Fenc%3AUTF-8&rfr_id=info%3Asid%2Fsummon.serialssolutions.com&rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&rft.genre=article&rft.atitle=The+involvement+of+central+nervous+system+across+the+phenotypic+spectrum+of+Pompe+disease%3A+a+systematic+review&rft.jtitle=Neuromuscular+disorders+%3A+NMD&rft.au=Torri%2C+Francesca&rft.au=Buchignani%2C+Bianca&rft.au=Unluturk%2C+Zeynep&rft.au=Vadi%2C+Gabriele&rft.date=2025-06-01&rft.issn=1873-2364&rft.eissn=1873-2364&rft.volume=51&rft.spage=105362&rft_id=info:doi/10.1016%2Fj.nmd.2025.105362&rft.externalDBID=NO_FULL_TEXT
thumbnail_l http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/lc.gif&issn=0960-8966&client=summon
thumbnail_m http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/mc.gif&issn=0960-8966&client=summon
thumbnail_s http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/sc.gif&issn=0960-8966&client=summon